LensAR

LensAR

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2019202020212022202320242025
Revenues30.5m26.4m34.5m35.4m42.2m50.8m61.7m
% growth-(14 %)31 %3 %19 %20 %21 %
EBITDA(8.8m)(17.2m)(18.4m)(19.0m)(5.9m)--
% EBITDA margin(29 %)(65 %)(53 %)(54 %)(14 %)--
Profit(14.7m)(19.8m)(19.6m)(19.9m)(14.4m)--
% profit margin(48 %)(75 %)(57 %)(56 %)(34 %)--
R&D budget7.6m7.6m12.4m11.8m6.1m--
R&D % of revenue25 %29 %36 %33 %15 %--
  • Edit
DateInvestorsAmountRound
N/A

$7.1m

Early VC
N/A

$7.0m

Early VC
N/A

$2.0m

Debt
N/A

$1.4m

Debt

$24.0m

Debt

$10.0m

Debt
N/A

N/A

Series A

$27.0m

-
N/A

$10.0m

Growth Equity VC
N/A

$16.0m

Growth Equity VC
Total FundingAUD104m

Recent News about LensAR

Edit
More about LensARinfo icon
Edit

LENSAR, Inc. is a pioneering company in the field of refractive cataract surgery, specializing in next-generation femtosecond laser technology. The company focuses on providing advanced laser systems that enable surgeons to perform personalized and precise cataract procedures. LENSAR serves ophthalmologists and their patients, primarily targeting the healthcare and medical device markets. The business model revolves around the sale of its laser systems and related services, generating revenue through direct sales and ongoing service agreements. By understanding the dynamic needs of surgeons and patients, LENSAR continuously innovates its technology to ensure optimal outcomes. The company operates in a highly specialized niche, offering unique solutions that enhance surgical precision and patient outcomes.

Keywords: femtosecond laser, cataract surgery, ophthalmology, medical devices, refractive surgery, precision, innovation, healthcare, personalized treatment, surgical technology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by LensAR

Edit
Precision Eye Services
ACQUISITION by LensAR Jan 2018